The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

 As per The Business Research Company’s Live Cell Imaging Global Market Report 2023, The global live cell imaging market is expected to grow from $3.75 billion in 2022 to $4.15 billion in 2023 at a compound annual growth rate (CAGR) of 10.7%. The market size of global live cell imaging is expected to grow to $6.22 billion in 2027 at a CAGR of 10.6%.

What was the major driver in the live cell imaging market?
The rising incidence of cancer is expected to drive the growth of the live cell imaging market in the forecast period. Cancer is the second major cause of death worldwide, accounting for one out of every six deaths each year. For example, cancer cases are projected to increase to 29.5 million and cancer-related deaths to 16.4 million worldwide by 2040. In the United States, there were 16.9 million cancer patients in 2019, with the number expected to rise to 22.2 million by 2030. Live cell imaging technology plays a crucial role in the advancement and validation of cancer immunotherapy through visualization, characterization, and evaluation of the biological process of living cells. Therefore, the rising incidence of cancer fuels the growth of the live cell imaging market.

View More On The Live Cell Imaging Market Report 2023 – https://www.thebusinessresearchcompany.com/report/live-cell-imaging-global-market-report

Which was the largest region in the live cell imaging market?
North America was the largest region in the live cell imaging market in 2022.  The regions covered in the live cell imaging market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Who are the live cell imaging market prominent players?
Major players in the live cell imaging market are Leica Microsystems, Olympus Corporation, Sigma-Aldrich Corporation, PerkinElmer Inc., GE Healthcare, Carl Zeiss Meditec AG, Becton Dickinson and Company, Molecular Devices LLC, Bruker Corporation, Sartorius AG, Oxford Instruments, BioTek Instruments, Etaluma Inc., and CytoSMART Technologies.

Key live cell imaging market segments
The global live cell imaging market is segmented –
1) By Product: Equipment, Consumable, Software
2) By Technology: Time-Lapse Microscopy, Fluorescence Recovery After Photobleaching (FRAP), Fluorescence Resonance Energy Transfer (FRET), High Content Screening (HCS), Other Technologies
3) By Application: Cell Biology, Developmental Biology, Stem Cell and Drug Discovery, Other Applications
4) By End-User: Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Contract Research Organizations (CROs)

Request A Sample Of The Global Live Cell Imaging Market Report 2023:
https://www.thebusinessresearchcompany.com/sample.aspx?id=4110&type=smp

The Live Cell Imaging Global Market Report 2023  provides a comprehensive overview on the live cell imaging market size, trends and drivers, opportunities, strategies, and companies analysis. Through our reports businesses can effectively analyze data and frame well-informed strategies

View More Related Reports –
Cell Culture Consumables And Equipment Global Market Report 2023
Cell Based Assays Global Market Report 2023
Cell Culture Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model